Evaluating an Emergency Department Observation Syncope Protocol for Older Adults
2 other identifiers
interventional
123
1 country
4
Brief Summary
Syncope, defined as a transient loss of consciousness, accounts for over 700,000 annual U.S. emergency department visits and may herald a life-threatening condition in older adults (age≥60 years). Existing risk prediction instruments cannot reliably identify who among such older patients can safely be discharged home from an emergency department. As a result, the majority of older patients without a clear cause for syncope are hospitalized for diagnostic evaluation. However, current admission practices are characterized by low diagnostic yield, do not clearly improve outcomes, and account for over $2.4 billion in annual hospital costs. Most admitted patients are discharged within 48 hours, and approximately 50% of patients do not have an identified cause of syncope after their hospitalization. The implementation of an expedited and standardized Emergency Department Observation Syncope Protocol (EDOSP) may safely reduce hospitalization of older patients with syncope. The investigators propose a pilot randomized trial to implement and evaluate EDOSP at two emergency departments. This study has the following exploratory Specific Aims:
- 1.To compare admission rates and length-of-stay associated with EDOSP to standard care.
- 2.To compare serious outcomes rates associated with EDOSP to standard care.
- 3.To compare quality-of-life associated with EDOSP to standard care.
- 4.To compare the incremental costs and cost-effectiveness of EDOSP to standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2010
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2009
CompletedFirst Posted
Study publicly available on registry
October 28, 2009
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFebruary 13, 2023
February 1, 2023
1.8 years
October 27, 2009
February 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Admission Rate
Enrollment date
Secondary Outcomes (3)
30 day clinical outcomes
30 days
Quality of life
30 days
Cost
30 Days
Study Arms (2)
Emergency Department Observation
EXPERIMENTALThe EDOSP will consist of cardiac enzyme testing, 12-24 hours of cardiac monitoring, and echocardiogram testing by explicit criteria
Unstructured, inpatient evaluation
ACTIVE COMPARATORInterventions
The EDOSP will consist of cardiac enzyme testing, 12-24 hours of cardiac monitoring, and echocardiogram testing by explicit criteria
This is unstructured management by an inpatient medical team.
Eligibility Criteria
You may qualify if:
- Age≥60 years
- A complaint of syncope or near-syncope (Syncope is defined as a sudden, transient loss of consciousness. Near-syncope is defined as a sensation of imminent loss of consciousness, without actual syncope.)
- Intermediate risk of adverse outcome (see Table)
- Patient speaks either English or Spanish as a primary language.
You may not qualify if:
- Syncope mimics (intoxication, weakness or dizziness with syncope/ near-syncope, hypoglycemia, and cardiac arrest)
- New or baseline cognitive impairment or dementia)
- Inability to provide follow-up information (e.g. homeless or resides outside of U.S.)
- Inability to speak Spanish or English
- Low- and high-risk patients (see Table).
- Risk Stratification Guidelines:
- High Risk
- Serious condition identified in ED
- History of ventricular arrhythmia
- Cardiac Device with dysfunction
- Presentation consistent with acute coronary ischemia
- Intermediate Risk
- No High Risk features
- Presentation not consistent with orthostatic or vasovagal syncope
- Low Risk
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Los Angeleslead
- University of Southern Californiacollaborator
- Brigham and Women's Hospitalcollaborator
- Corewell Health Eastcollaborator
- Duke Universitycollaborator
- National Institute on Aging (NIA)collaborator
Study Sites (4)
University of Southern California
Los Angeles, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
William Beaumont Hospital
Royal Oaks, Michigan, 48073, United States
Duke University Medical Center
Durham, North Carolina, 27705, United States
Related Publications (1)
Sun BC, McCreath H, Liang LJ, Bohan S, Baugh C, Ragsdale L, Henderson SO, Clark C, Bastani A, Keeler E, An R, Mangione CM. Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission. Ann Emerg Med. 2014 Aug;64(2):167-75. doi: 10.1016/j.annemergmed.2013.10.029. Epub 2013 Nov 13.
PMID: 24239341RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Sun, MD, MPP
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2009
First Posted
October 28, 2009
Study Start
March 1, 2010
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
February 13, 2023
Record last verified: 2023-02